Oliveira, Paula AlexandraCosta, Rui Gil daNóbrega, CarmenRodrigues, Regina ArantesLeite, Rosário Pinto2017-01-032017-01-032016-04-28Oliveira, P.A., Costa, R. M.G., Nóbrega, C.V., Rodrigues, R.A. & Leite, R. P. (2016). Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery. "Expert opinion on drug discovery", 11(6),599-607. Retrieved fromhttp://www.tandfonline.com/doi/abs/10.1080/17460441.2016.1174690?journalCode=iedc20.http://hdl.handle.net/10400.19/3587Urinary bladder cancer (UBC) is the second most frequent malignancy of the urinary system and the ninth most common cancer worldwide, affecting individuals over the age of 65. Several investigations have embarked on advancing knowledge of the mechanisms underlying urothelial carcinogenesis, understanding the mechanisms of antineoplastic drugs resistance and discovering new antineoplastic drugs. In vitro and in vivo models are crucial for providing additional insights into the mechanisms of urothelial carcinogenesis. With these models, various molecular pathways involved in urothelial carcinogenesis have been discovered, allowing therapeutic manipulation.engAnimal modelsantineoplastic drugscell culturetreatmenttumorurothelialjournal article